Back to Journals » ClinicoEconomics and Outcomes Research » Volume 4
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Economic evaluation of bevacizumab in the treatment of non-small cell lung cancer (NSCLC)
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
11,836 | Dovepress* | 10,177+ | 2,225 | 12,402 | |
PubMed Central* | 1,659 | 1,381 | 3,040 | ||
Totals | 11,836 | 3,606 | 15,442 | ||
*Since 25 July 2012 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
5 | 0 | 0 | 0 | 1 | 4 |
View citations on PubMed and Google Scholar